Skip to main content
BMC Musculoskeletal Disorders logoLink to BMC Musculoskeletal Disorders
. 2022 Jun 6;23:541. doi: 10.1186/s12891-022-05424-4

Correction: Antioxidant effect of nicotinamide mononucleotide in tendinopathy

Kohei Yamaura 1, Yutaka Mifune 1,, Atsuyuki Inui 1, Hanako Nishimoto 1, Takashi Kurosawa 1, Shintaro Mukohara 1, Yuichi Hoshino 1, Takahiro Niikura 1, Ryosuke Kuroda 1
PMCID: PMC9169315  PMID: 35668405

Correction: BMC Musculoskelet Disord 23, 249 (2022)

https://doi.org/10.1186/s12891-022-05205-z

Following the publication of the original article [1] the author noticed that the published Fig. 8 is incorrect.

Fig. 8.

Fig. 8

Quantitative expression of SIRT1, SIRT6, and IL6 mRNA in vivo. Quantitative RT-PCR results showing the mRNA expression of SIRT1, SIRT6, and IL6 in an in vivo collagenase-induced tendinopathy model. Expression is shown for the NMN group and the control group. The expression of IL6 was significantly suppressed in the NMN group compared to the control group, whereas the expression of SIRT1 and SIRT6 was significantly increased in the NMN group compared to the control group. * p < 0.05; ** p < 0.0001

The original article [1] has been updated.

Below is the correct Fig. 8.

Reference

  • 1.Yamaura K, Mifune Y, Inui A, et al. Antioxidant effect of nicotinamide mononucleotide in tendinopathy. BMC Musculoskelet Disord. 2022;23:249. doi: 10.1186/s12891-022-05205-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Musculoskeletal Disorders are provided here courtesy of BMC

RESOURCES